Rare disease is a complex area and one the pharmaceutical industry has been heavily criticized on.
This Sifted/Financial Times story tells how Roche is transforming its #raredisease unit, by establishing a relationship with rare disease patient communities, helping these communities around the world and making them part of the company’s ecosystem.
![](http://s892653701.onlinehome.us/wp-content/uploads/2022/03/KFB_ARTICLE_COVER_INNOVATION_02.png)